Home - Products - Others - Other Targets - N,N,O-Tridesmethylvenlafaxine

N,N,O-Tridesmethylvenlafaxine

CAS No. 149289-29-2

N,N,O-Tridesmethylvenlafaxine( Tridesmethylvenlafaxine )

Catalog No. M28629 CAS No. 149289-29-2

N,N,O-Tridesmethylvenlafaxine is an endogenous metabolite.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 178 Get Quote
10MG 267 Get Quote
25MG 464 Get Quote
50MG 662 Get Quote
100MG 888 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    N,N,O-Tridesmethylvenlafaxine
  • Note
    Research use only, not for human use.
  • Brief Description
    N,N,O-Tridesmethylvenlafaxine is an endogenous metabolite.
  • Description
    N,N,O-Tridesmethylvenlafaxine is an endogenous metabolite.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tridesmethylvenlafaxine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ROCK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    149289-29-2
  • Formula Weight
    235.32
  • Molecular Formula
    C14H21NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NCC(C1(CCCCC1)O)c(cc1)ccc1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tokushige H, et al. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3216-22.
molnova catalog
related products
  • PROTAC-O4I2

    PROTAC-O4I2, a PROTAC ligand targeting splicing factor 3B1 (SF3B1), induced FLAG-SF3B1 degradation in K562 cells with an IC50 value of 0.244 μM. PROTAC-O4I2 induced apoptosis in K562 WT cells.

  • A-18-F-NH2

    A-18-F-NH2; Morphine Modulating Neuropeptide

  • Tetramethylammonium

    Tetramethylammonium ion has limited toxicity of dermal exposure, but fatal effects can be introduced by pre-treatment with hydroxide ion.